Elder Pharmaceuticals (Delisted) share news and announcements

BSE: 532322

Last traded ₹38.00 on 12 Sep 2016

Delisted on 11 May 2018.

Elder Pharmaceuticals share news and announcements

562 announcements, routine notices left out, newest first. Page 8 of 12.

Dec 2012
- 11 Dec · Disclosure
  Indarts Exports Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 5 Dec · Legal
  With reference to Increase in Volume, Elder Pharmaceuticals Ltd has clarified to BSE that: "in the recent past there has not been any development in the Company or any information/announcement ....
- 5 Dec · Legal
  Spurt in Volume : Substantial increase in trading volumes have been observed in Elder Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "In the recent past there has not been any development in the Company or any information/announcement (including pending announcement) which in our opinion may have a bearing on the price/volume behavior in the scrip".
- 4 Dec · Disclosure
  Vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 3 Dec · Disclosure
  Niti Saxena has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 3 Dec · Disclosure
  Vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 3 Dec · Disclosure
  Vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Nov 2012
- 30 Nov · Disclosure
  Semit Pharmaceuticals & Chemicals Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 30 Nov · Disclosure
  Akshaya Holdings Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 6 Nov · Business
  Press release dated November 05, 2012 titled "Elder Pharmaceuticals Ltd. has received the Certificate of Suitability (cos) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for DIOSMIN API. (opens in a new tab)
- 6 Nov · Management
  Press Release dated November 05, 2012 titled "Elder Pharmaceuticals Ltd. has received the Certificate of Suitability (COS) from EDQM .... (opens in a new tab)
- 5 Nov · Results
  Standalone and Consolidated Financial Results for the period ended September 30,2012. (opens in a new tab)
- 2 Nov · Board meeting
  Board of Directors of the Company at its meeting held on November 02, 2012, has decided to appoint Mr. James Mceuen as an additional ....
- 2 Nov · Results
  Financial Results & a copy of the Limited Review Report for the period ended September 30, 2012. (opens in a new tab)
Oct 2012
- 19 Oct · Board meeting
  To consider the un-audited provisional financial results of the Company for the quarter ended September 30, 2012.
- 12 Oct · Disclosure
  Alok Saxena has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 10 Oct · Disclosure
  Jagdish Saxena & Sneh Saxena has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Sep 2012
Aug 2012
- 10 Aug · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2012 to September 28, 2012 (both days ....
- 10 Aug · Results
  Standalone and Consolidated Financial Results for the period ended March 31,2012. (opens in a new tab)
- 10 Aug · Results
  Audited Financial Results for the period ended March 31, 2012. (opens in a new tab)
- 10 Aug · Meeting
  Annual General Meeting of the Company is scheduled to be held on September 28, 2012. Further the Share transfer books closed from September 20, 2012 to September 28, 2012 (both days inclusive) for payment of dividend.
- 9 Aug · Management
  Board of Directors of the Company at its meeting held on August 09, 2012 have re-appoint Mr. Yusuf Karim Khan as Executive Director for a period of five years w.e.f. August 28, 2012, subject to approval of the shareholders at the ensuing Annual General Meeting and appropriate authorities, if any.
- 9 Aug · Dividend
  Board of Directors of the Company at its meeting held on August 09, 2012 have recommend for consideration of Shareholders declaration of dividend @ 30% i.e. Rs.3/- per share of Rs.10/- each.
- 9 Aug · Results
  Financial Results & a copy of the Limited Review Report for the period ended June 30, 2012. (opens in a new tab)
- 9 Aug · Dividend
  Board of Directors of the Company at its meeting held on August 09, 2012, inter alia, has taken the following decisions: 1. To ....
- 2 Aug · Board meeting
  Outcome of Board Meeting held on August 02, 2012. (opens in a new tab)
- 2 Aug · Board meeting
  Board of Directors of the Company at its meeting held on August 02, 2012, inter alia, has approved the following: 1. Scheme of .... (opens in a new tab)
- 1 Aug · Board meeting
  To consider the un-audited provisional financial results of the Company for the quarter ended June 30, 2012. Further, the following matters will also be decided: 1) Approval of audited financial results of the Company for the year ended March 31, 2012; 2) Recommendation of dividend for the year ended March 31, 2012 and 3) Date of the Annual General Meeting of the Company and book closure date, if any.
Jul 2012
- 31 Jul · Board meeting
  Interalia, to consider and explore various strategic growth options and opportunities available for the Company and matters relating thereto.
- 31 Jul · Board meeting
  Meeting of the Board of Directors of the Company will be held on August 09, 2012, inter alia, to transact the following: 1. To consider ....
- 31 Jul · Board Meeting on Aug 02, 2012
  Meeting of the Board of Directors of the Company will be held on August 02, 2012, inter alia, to consider and explore various strategic ....
Jun 2012
- 18 Jun · Disclosure
  Akshaya Holdings Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 14 Jun · Disclosure
  Vide its letter dated June 12, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
May 2012
- 16 May · Results
  With reference to the earlier announcement regarding Financial Results for March 31, 2012, Elder Pharmaceuticals Ltd Elder Pharmaceuticals Ltd has now informed BSE that there was a typographical .... (opens in a new tab)
- 15 May · Results
  Standalone and Consolidated Financial Results along with the Limited Review Report for the period ended March 31,2012. (opens in a new tab)
- 15 May · Results
  Financial Results & a copy of the Limited Review Report for the period ended March 31, 2012. (opens in a new tab)
- 8 May · Legal
  With reference to the news item "Elder Pharma weighs sale of nutrition business" appearing on various media websites, the Company hereby clarify that the Company has no intentions to sell any business nor is in any discussion with any party. The Company's Joint Managing Director has already denied in the said news item that the Company was looking to sell any Business.
- 7 May · Legal
  With reference to the item “Elder Pharma weighs sale of nutrition business” appearing on various media websites, Elder Pharmaceuticals Ltd has clarified to BSE that, the Company has no ....
- 4 May · Disclosure
  Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 4 May · Disclosure
  Vide its letter dated April 27, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Apr 2012
- 30 Apr · Disclosure
  Semit Pharmaceuticals & Chemicals Pvt Ltd and Indarts Exports Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) .... (opens in a new tab)
- 30 Apr · Board meeting
  To consider the un-audited provisional financial results of the Company for the quarter ended March 31, 2012.
- 10 Apr · Disclosure
  Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 10 Apr · Disclosure
  Indarts Exports Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE: (opens in a new tab)
Mar 2012